2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp2
|
ENSMUSG00000029563.10 | forkhead box P2 |
Foxp3
|
ENSMUSG00000039521.6 | forkhead box P3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp3 | mm10_v2_chrX_+_7580483_7580491 | 0.89 | 9.8e-05 | Click! |
Foxp2 | mm10_v2_chr6_+_14901344_14901364 | 0.88 | 1.7e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_138171248 | 4.26 |
ENSMUST00000153867.1
|
Mcm7
|
minichromosome maintenance deficient 7 (S. cerevisiae) |
chr3_-_27153861 | 3.90 |
ENSMUST00000108300.1
ENSMUST00000108298.2 |
Ect2
|
ect2 oncogene |
chr12_-_103773592 | 3.82 |
ENSMUST00000078869.5
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr12_-_103904887 | 3.74 |
ENSMUST00000074051.5
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr7_+_141476374 | 3.74 |
ENSMUST00000117634.1
|
Tspan4
|
tetraspanin 4 |
chr3_-_27153844 | 3.61 |
ENSMUST00000176242.2
ENSMUST00000176780.1 |
Ect2
|
ect2 oncogene |
chr5_-_138170992 | 3.56 |
ENSMUST00000139983.1
|
Mcm7
|
minichromosome maintenance deficient 7 (S. cerevisiae) |
chr3_-_27153782 | 3.29 |
ENSMUST00000175857.1
ENSMUST00000177055.1 ENSMUST00000176535.1 |
Ect2
|
ect2 oncogene |
chr4_-_82885148 | 3.28 |
ENSMUST00000048430.3
|
Cer1
|
cerberus 1 homolog (Xenopus laevis) |
chr10_+_88091070 | 3.18 |
ENSMUST00000048621.7
|
Pmch
|
pro-melanin-concentrating hormone |
chr12_-_103863551 | 3.02 |
ENSMUST00000085056.6
ENSMUST00000072876.5 ENSMUST00000124717.1 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr12_+_109452833 | 2.57 |
ENSMUST00000056110.8
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr18_-_47333311 | 2.41 |
ENSMUST00000126684.1
ENSMUST00000156422.1 |
Sema6a
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr9_+_7272514 | 2.24 |
ENSMUST00000015394.8
|
Mmp13
|
matrix metallopeptidase 13 |
chr15_+_78430086 | 2.24 |
ENSMUST00000162808.1
|
Kctd17
|
potassium channel tetramerisation domain containing 17 |
chr4_+_11191726 | 2.19 |
ENSMUST00000029866.9
ENSMUST00000108324.3 |
Ccne2
|
cyclin E2 |
chr5_-_138171216 | 2.02 |
ENSMUST00000147920.1
|
Mcm7
|
minichromosome maintenance deficient 7 (S. cerevisiae) |
chr17_+_7925990 | 1.92 |
ENSMUST00000036370.7
|
Tagap
|
T cell activation Rho GTPase activating protein |
chr1_-_130661613 | 1.86 |
ENSMUST00000027657.7
|
C4bp
|
complement component 4 binding protein |
chr1_+_130865669 | 1.84 |
ENSMUST00000038829.5
|
Faim3
|
Fas apoptotic inhibitory molecule 3 |
chr17_-_34627365 | 1.71 |
ENSMUST00000064953.8
ENSMUST00000170345.1 ENSMUST00000171121.2 ENSMUST00000168391.2 ENSMUST00000169067.2 |
Ppt2
|
palmitoyl-protein thioesterase 2 |
chr17_-_34627148 | 1.66 |
ENSMUST00000171376.1
ENSMUST00000169287.1 |
Ppt2
|
palmitoyl-protein thioesterase 2 |
chr8_-_84773381 | 1.65 |
ENSMUST00000109764.1
|
Nfix
|
nuclear factor I/X |
chr16_-_4559720 | 1.56 |
ENSMUST00000005862.7
|
Tfap4
|
transcription factor AP4 |
chr12_-_103738158 | 1.52 |
ENSMUST00000095450.4
|
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr4_-_133967235 | 1.49 |
ENSMUST00000123234.1
|
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chr3_+_68584154 | 1.49 |
ENSMUST00000182997.1
|
Schip1
|
schwannomin interacting protein 1 |
chr6_+_79818031 | 1.46 |
ENSMUST00000179797.1
|
Gm20594
|
predicted gene, 20594 |
chr2_+_118598209 | 1.44 |
ENSMUST00000038341.7
|
Bub1b
|
budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) |
chr6_-_125191535 | 1.43 |
ENSMUST00000043848.4
|
Ncapd2
|
non-SMC condensin I complex, subunit D2 |
chr3_-_27896360 | 1.42 |
ENSMUST00000058077.3
|
Tmem212
|
transmembrane protein 212 |
chr17_-_70851710 | 1.41 |
ENSMUST00000166395.2
|
Tgif1
|
TGFB-induced factor homeobox 1 |
chr1_-_130661584 | 1.37 |
ENSMUST00000137276.2
|
C4bp
|
complement component 4 binding protein |
chr11_+_97685903 | 1.34 |
ENSMUST00000107583.2
|
Cisd3
|
CDGSH iron sulfur domain 3 |
chr6_-_39557830 | 1.33 |
ENSMUST00000036877.3
ENSMUST00000154149.1 |
Dennd2a
|
DENN/MADD domain containing 2A |
chr6_+_14901344 | 1.30 |
ENSMUST00000115477.1
|
Foxp2
|
forkhead box P2 |
chr15_-_79285470 | 1.27 |
ENSMUST00000170955.1
|
Baiap2l2
|
BAI1-associated protein 2-like 2 |
chr18_+_5593566 | 1.24 |
ENSMUST00000160910.1
|
Zeb1
|
zinc finger E-box binding homeobox 1 |
chr11_-_102925086 | 1.24 |
ENSMUST00000021311.9
|
Kif18b
|
kinesin family member 18B |
chr4_-_129121889 | 1.22 |
ENSMUST00000139450.1
ENSMUST00000125931.1 ENSMUST00000116444.2 |
Hpca
|
hippocalcin |
chr16_-_92400067 | 1.18 |
ENSMUST00000023672.8
|
Rcan1
|
regulator of calcineurin 1 |
chr3_-_33082004 | 1.17 |
ENSMUST00000108225.3
|
Pex5l
|
peroxisomal biogenesis factor 5-like |
chr17_+_29090969 | 1.16 |
ENSMUST00000119901.1
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A (P21) |
chr2_+_32095518 | 1.16 |
ENSMUST00000057423.5
|
Ppapdc3
|
phosphatidic acid phosphatase type 2 domain containing 3 |
chr3_+_53488677 | 1.14 |
ENSMUST00000029307.3
|
Stoml3
|
stomatin (Epb7.2)-like 3 |
chr5_-_96164147 | 1.13 |
ENSMUST00000137207.1
|
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr1_+_53061637 | 1.12 |
ENSMUST00000027269.5
|
Mstn
|
myostatin |
chr19_+_30232921 | 1.12 |
ENSMUST00000025797.5
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr6_-_148946146 | 1.10 |
ENSMUST00000132696.1
|
Fam60a
|
family with sequence similarity 60, member A |
chr9_+_47530173 | 1.07 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr14_-_55116935 | 1.07 |
ENSMUST00000022819.5
|
Jph4
|
junctophilin 4 |
chr5_-_148392810 | 1.07 |
ENSMUST00000138257.1
|
Slc7a1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr2_-_152398046 | 1.05 |
ENSMUST00000063332.8
ENSMUST00000182625.1 |
Sox12
|
SRY-box containing gene 12 |
chr10_-_49783259 | 1.05 |
ENSMUST00000105484.3
ENSMUST00000105486.1 ENSMUST00000079751.2 ENSMUST00000105485.1 |
Grik2
|
glutamate receptor, ionotropic, kainate 2 (beta 2) |
chr1_+_171225054 | 1.04 |
ENSMUST00000111321.1
ENSMUST00000005824.5 ENSMUST00000111320.1 ENSMUST00000111319.1 |
Apoa2
|
apolipoprotein A-II |
chr5_+_31251678 | 1.04 |
ENSMUST00000054829.7
ENSMUST00000114570.1 ENSMUST00000075611.7 |
Krtcap3
|
keratinocyte associated protein 3 |
chr15_+_3270767 | 1.03 |
ENSMUST00000082424.4
ENSMUST00000159158.1 ENSMUST00000159216.1 ENSMUST00000160311.1 |
Sepp1
|
selenoprotein P, plasma, 1 |
chr5_-_90640464 | 1.02 |
ENSMUST00000031317.6
|
Rassf6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr12_-_71136611 | 0.99 |
ENSMUST00000021486.8
ENSMUST00000166120.1 |
Timm9
|
translocase of inner mitochondrial membrane 9 |
chr16_-_63864114 | 0.92 |
ENSMUST00000064405.6
|
Epha3
|
Eph receptor A3 |
chr6_+_135362931 | 0.92 |
ENSMUST00000032330.9
|
Emp1
|
epithelial membrane protein 1 |
chr1_+_34005872 | 0.92 |
ENSMUST00000182296.1
|
Dst
|
dystonin |
chr1_-_179546261 | 0.92 |
ENSMUST00000027769.5
|
Tfb2m
|
transcription factor B2, mitochondrial |
chrX_+_56786527 | 0.91 |
ENSMUST00000144600.1
|
Fhl1
|
four and a half LIM domains 1 |
chr7_+_19291070 | 0.91 |
ENSMUST00000108468.3
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr14_+_115042752 | 0.90 |
ENSMUST00000134140.2
|
Mir17hg
|
Mir17 host gene 1 (non-protein coding) |
chr12_-_11265768 | 0.89 |
ENSMUST00000166117.1
|
Gen1
|
Gen homolog 1, endonuclease (Drosophila) |
chr6_-_23132981 | 0.87 |
ENSMUST00000031707.7
|
Aass
|
aminoadipate-semialdehyde synthase |
chr10_+_60106452 | 0.85 |
ENSMUST00000165024.2
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr9_+_78113275 | 0.84 |
ENSMUST00000009972.5
ENSMUST00000117330.1 ENSMUST00000044551.7 |
Ick
|
intestinal cell kinase |
chr15_-_79285502 | 0.84 |
ENSMUST00000165408.1
|
Baiap2l2
|
BAI1-associated protein 2-like 2 |
chr1_+_66386968 | 0.83 |
ENSMUST00000145419.1
|
Map2
|
microtubule-associated protein 2 |
chr3_+_107230608 | 0.80 |
ENSMUST00000179399.1
|
A630076J17Rik
|
RIKEN cDNA A630076J17 gene |
chr2_+_181767040 | 0.80 |
ENSMUST00000108756.1
|
Myt1
|
myelin transcription factor 1 |
chr5_-_149051604 | 0.79 |
ENSMUST00000093196.4
|
Hmgb1
|
high mobility group box 1 |
chr10_+_18235030 | 0.78 |
ENSMUST00000181897.1
|
Gm10827
|
predicted gene 10827 |
chr4_-_87806296 | 0.78 |
ENSMUST00000126353.1
ENSMUST00000149357.1 |
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr7_+_141061274 | 0.78 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr14_+_64589802 | 0.78 |
ENSMUST00000180610.1
|
A930011O12Rik
|
RIKEN cDNA A930011O12 gene |
chr4_+_11579647 | 0.78 |
ENSMUST00000180239.1
|
Fsbp
|
fibrinogen silencer binding protein |
chr2_+_181767283 | 0.77 |
ENSMUST00000108757.2
|
Myt1
|
myelin transcription factor 1 |
chr9_-_14782964 | 0.76 |
ENSMUST00000034406.3
|
Ankrd49
|
ankyrin repeat domain 49 |
chr11_+_70054334 | 0.76 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr13_+_55445301 | 0.74 |
ENSMUST00000001115.8
ENSMUST00000099482.3 |
Grk6
|
G protein-coupled receptor kinase 6 |
chr7_+_82175156 | 0.73 |
ENSMUST00000180243.1
|
Sh3gl3
|
SH3-domain GRB2-like 3 |
chr11_-_52282564 | 0.73 |
ENSMUST00000086844.3
|
Tcf7
|
transcription factor 7, T cell specific |
chr1_+_161070767 | 0.73 |
ENSMUST00000111618.1
ENSMUST00000111620.3 ENSMUST00000028035.7 |
Cenpl
|
centromere protein L |
chr19_+_53329413 | 0.72 |
ENSMUST00000025998.7
|
Mxi1
|
Max interacting protein 1 |
chr9_+_119402444 | 0.71 |
ENSMUST00000035093.8
ENSMUST00000165044.1 |
Acvr2b
|
activin receptor IIB |
chr14_+_14820765 | 0.70 |
ENSMUST00000112631.2
ENSMUST00000178538.1 ENSMUST00000112630.2 |
Nek10
|
NIMA (never in mitosis gene a)- related kinase 10 |
chr2_-_28916412 | 0.70 |
ENSMUST00000050776.2
ENSMUST00000113849.1 |
Barhl1
|
BarH-like 1 (Drosophila) |
chr17_+_71204647 | 0.69 |
ENSMUST00000126681.1
|
Lpin2
|
lipin 2 |
chr15_+_25940846 | 0.69 |
ENSMUST00000110438.1
|
Fam134b
|
family with sequence similarity 134, member B |
chr10_+_127677064 | 0.69 |
ENSMUST00000118612.1
ENSMUST00000048099.4 |
Tmem194
|
transmembrane protein 194 |
chr13_+_60602182 | 0.69 |
ENSMUST00000044083.7
|
Dapk1
|
death associated protein kinase 1 |
chr6_-_39725193 | 0.69 |
ENSMUST00000101497.3
|
Braf
|
Braf transforming gene |
chr8_+_66386292 | 0.68 |
ENSMUST00000039540.5
ENSMUST00000110253.2 |
March1
|
membrane-associated ring finger (C3HC4) 1 |
chr9_-_44713196 | 0.68 |
ENSMUST00000144251.1
ENSMUST00000156918.1 |
Phldb1
|
pleckstrin homology-like domain, family B, member 1 |
chr18_+_56707725 | 0.67 |
ENSMUST00000025486.8
|
Lmnb1
|
lamin B1 |
chr9_-_45955170 | 0.67 |
ENSMUST00000162072.1
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr6_-_24527546 | 0.67 |
ENSMUST00000118558.1
|
Ndufa5
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 |
chrX_+_139800795 | 0.66 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr6_+_21985903 | 0.65 |
ENSMUST00000137437.1
ENSMUST00000115383.2 |
Cped1
|
cadherin-like and PC-esterase domain containing 1 |
chr7_+_130692532 | 0.65 |
ENSMUST00000033141.6
|
Tacc2
|
transforming, acidic coiled-coil containing protein 2 |
chr7_+_140763739 | 0.64 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr13_+_55209776 | 0.64 |
ENSMUST00000099490.2
|
Nsd1
|
nuclear receptor-binding SET-domain protein 1 |
chr1_+_88406956 | 0.64 |
ENSMUST00000027518.5
|
Spp2
|
secreted phosphoprotein 2 |
chr6_+_21986438 | 0.63 |
ENSMUST00000115382.1
|
Cped1
|
cadherin-like and PC-esterase domain containing 1 |
chr7_-_62420139 | 0.63 |
ENSMUST00000094340.3
|
Mkrn3
|
makorin, ring finger protein, 3 |
chr2_-_148040196 | 0.63 |
ENSMUST00000136555.1
|
9030622O22Rik
|
RIKEN cDNA 9030622O22 gene |
chr5_-_149051300 | 0.63 |
ENSMUST00000110505.1
|
Hmgb1
|
high mobility group box 1 |
chrX_+_68678712 | 0.63 |
ENSMUST00000114654.1
ENSMUST00000114655.1 ENSMUST00000114657.2 ENSMUST00000114653.1 |
Fmr1
|
fragile X mental retardation syndrome 1 |
chr9_+_78615501 | 0.63 |
ENSMUST00000093812.4
|
Cd109
|
CD109 antigen |
chr5_-_17888884 | 0.62 |
ENSMUST00000169095.1
|
Cd36
|
CD36 antigen |
chrX_+_159303266 | 0.62 |
ENSMUST00000112491.1
|
Rps6ka3
|
ribosomal protein S6 kinase polypeptide 3 |
chr2_+_35132194 | 0.62 |
ENSMUST00000113034.1
ENSMUST00000113037.3 ENSMUST00000113033.2 |
Cep110
|
centrosomal protein 110 |
chr14_-_32685246 | 0.62 |
ENSMUST00000096038.3
|
3425401B19Rik
|
RIKEN cDNA 3425401B19 gene |
chr15_-_55548164 | 0.61 |
ENSMUST00000165356.1
|
Mrpl13
|
mitochondrial ribosomal protein L13 |
chr1_-_170110491 | 0.61 |
ENSMUST00000027985.2
|
Ddr2
|
discoidin domain receptor family, member 2 |
chr19_-_46039621 | 0.60 |
ENSMUST00000056931.7
|
Ldb1
|
LIM domain binding 1 |
chr11_+_97685794 | 0.59 |
ENSMUST00000107584.1
ENSMUST00000107585.2 |
Cisd3
|
CDGSH iron sulfur domain 3 |
chr18_+_69344503 | 0.58 |
ENSMUST00000114985.3
|
Tcf4
|
transcription factor 4 |
chr15_+_4375462 | 0.58 |
ENSMUST00000061925.4
|
Plcxd3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
chr15_+_59648644 | 0.58 |
ENSMUST00000118228.1
|
Trib1
|
tribbles homolog 1 (Drosophila) |
chr12_+_108605757 | 0.58 |
ENSMUST00000109854.2
|
Evl
|
Ena-vasodilator stimulated phosphoprotein |
chr10_+_39420009 | 0.58 |
ENSMUST00000157009.1
|
Fyn
|
Fyn proto-oncogene |
chr3_+_129532386 | 0.57 |
ENSMUST00000071402.2
|
Elovl6
|
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
chr12_-_91746020 | 0.57 |
ENSMUST00000166967.1
|
Ston2
|
stonin 2 |
chr1_-_161070613 | 0.57 |
ENSMUST00000035430.3
|
Dars2
|
aspartyl-tRNA synthetase 2 (mitochondrial) |
chr6_-_87335758 | 0.57 |
ENSMUST00000042025.9
|
Antxr1
|
anthrax toxin receptor 1 |
chr8_-_31918203 | 0.56 |
ENSMUST00000073884.4
|
Nrg1
|
neuregulin 1 |
chr5_+_3928033 | 0.56 |
ENSMUST00000143365.1
|
Akap9
|
A kinase (PRKA) anchor protein (yotiao) 9 |
chr8_+_31091593 | 0.56 |
ENSMUST00000161713.1
|
Dusp26
|
dual specificity phosphatase 26 (putative) |
chr8_+_20136455 | 0.56 |
ENSMUST00000179299.1
ENSMUST00000096485.4 |
Gm21811
|
predicted gene, 21811 |
chr2_-_51149100 | 0.56 |
ENSMUST00000154545.1
ENSMUST00000017288.2 |
Rnd3
|
Rho family GTPase 3 |
chrX_+_68678541 | 0.55 |
ENSMUST00000088546.5
|
Fmr1
|
fragile X mental retardation syndrome 1 |
chr2_-_64975762 | 0.54 |
ENSMUST00000156765.1
|
Grb14
|
growth factor receptor bound protein 14 |
chr2_+_38511643 | 0.54 |
ENSMUST00000054234.3
ENSMUST00000112902.1 ENSMUST00000112895.1 |
Nek6
|
NIMA (never in mitosis gene a)-related expressed kinase 6 |
chr2_-_28916668 | 0.53 |
ENSMUST00000113847.1
|
Barhl1
|
BarH-like 1 (Drosophila) |
chr12_-_76795489 | 0.53 |
ENSMUST00000082431.3
|
Gpx2
|
glutathione peroxidase 2 |
chr7_+_81862674 | 0.53 |
ENSMUST00000119543.1
|
Tm6sf1
|
transmembrane 6 superfamily member 1 |
chr2_+_122028544 | 0.52 |
ENSMUST00000028668.7
|
Eif3j1
|
eukaryotic translation initiation factor 3, subunit J1 |
chr19_-_28010995 | 0.52 |
ENSMUST00000172907.1
ENSMUST00000046898.9 |
Rfx3
|
regulatory factor X, 3 (influences HLA class II expression) |
chr2_+_4882204 | 0.52 |
ENSMUST00000115019.1
|
Sephs1
|
selenophosphate synthetase 1 |
chrX_-_168123311 | 0.51 |
ENSMUST00000112149.1
|
Frmpd4
|
FERM and PDZ domain containing 4 |
chr2_-_176917518 | 0.51 |
ENSMUST00000108931.2
|
Gm14296
|
predicted gene 14296 |
chr8_+_70373541 | 0.50 |
ENSMUST00000003659.7
|
Comp
|
cartilage oligomeric matrix protein |
chr8_-_62123106 | 0.50 |
ENSMUST00000034052.6
ENSMUST00000034054.7 |
Anxa10
|
annexin A10 |
chr4_-_19922599 | 0.50 |
ENSMUST00000029900.5
|
Atp6v0d2
|
ATPase, H+ transporting, lysosomal V0 subunit D2 |
chr12_+_71170589 | 0.50 |
ENSMUST00000129376.1
|
2700049A03Rik
|
RIKEN cDNA 2700049A03 gene |
chr3_+_76075583 | 0.50 |
ENSMUST00000160261.1
|
Fstl5
|
follistatin-like 5 |
chr2_-_20943413 | 0.50 |
ENSMUST00000140230.1
|
Arhgap21
|
Rho GTPase activating protein 21 |
chr4_+_11191354 | 0.50 |
ENSMUST00000170901.1
|
Ccne2
|
cyclin E2 |
chr1_-_9631092 | 0.50 |
ENSMUST00000115480.1
|
2610203C22Rik
|
RIKEN cDNA 2610203C22 gene |
chr7_+_16310412 | 0.50 |
ENSMUST00000136781.1
|
Bbc3
|
BCL2 binding component 3 |
chr18_-_43059418 | 0.49 |
ENSMUST00000025377.7
|
Ppp2r2b
|
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform |
chr14_+_48120841 | 0.49 |
ENSMUST00000073150.4
|
Peli2
|
pellino 2 |
chr6_+_34598530 | 0.49 |
ENSMUST00000115027.1
ENSMUST00000115026.1 |
Cald1
|
caldesmon 1 |
chr3_-_123236134 | 0.49 |
ENSMUST00000106427.1
ENSMUST00000106426.1 ENSMUST00000051443.5 |
Synpo2
|
synaptopodin 2 |
chr8_+_58912257 | 0.48 |
ENSMUST00000160055.1
|
BC030500
|
cDNA sequence BC030500 |
chr8_-_41417042 | 0.48 |
ENSMUST00000033999.6
|
Frg1
|
FSHD region gene 1 |
chrM_-_14060 | 0.47 |
ENSMUST00000082419.1
|
mt-Nd6
|
mitochondrially encoded NADH dehydrogenase 6 |
chr18_-_88927447 | 0.47 |
ENSMUST00000147313.1
|
Socs6
|
suppressor of cytokine signaling 6 |
chr12_+_38780817 | 0.47 |
ENSMUST00000160856.1
|
Etv1
|
ets variant gene 1 |
chr3_-_50443603 | 0.47 |
ENSMUST00000029297.4
|
Slc7a11
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
chr11_+_116434087 | 0.47 |
ENSMUST00000057676.6
|
Ubald2
|
UBA-like domain containing 2 |
chr18_-_39489157 | 0.47 |
ENSMUST00000131885.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr4_-_133967953 | 0.46 |
ENSMUST00000102553.4
|
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chr2_+_31670714 | 0.46 |
ENSMUST00000038474.7
ENSMUST00000137156.1 |
Exosc2
|
exosome component 2 |
chr8_+_19682268 | 0.46 |
ENSMUST00000153710.1
ENSMUST00000127799.1 |
Gm6483
|
predicted gene 6483 |
chr11_-_99155067 | 0.45 |
ENSMUST00000103134.3
|
Ccr7
|
chemokine (C-C motif) receptor 7 |
chr1_+_87574016 | 0.45 |
ENSMUST00000166259.1
ENSMUST00000172222.1 ENSMUST00000163606.1 |
Neu2
|
neuraminidase 2 |
chr6_+_53573364 | 0.45 |
ENSMUST00000047450.7
|
Creb5
|
cAMP responsive element binding protein 5 |
chr12_-_84400851 | 0.45 |
ENSMUST00000117286.1
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5 |
chr7_+_130577334 | 0.45 |
ENSMUST00000059145.7
ENSMUST00000084513.4 |
Tacc2
|
transforming, acidic coiled-coil containing protein 2 |
chr6_+_34598500 | 0.44 |
ENSMUST00000079391.3
ENSMUST00000142512.1 |
Cald1
|
caldesmon 1 |
chr12_+_71136848 | 0.44 |
ENSMUST00000149564.1
ENSMUST00000045907.8 |
2700049A03Rik
|
RIKEN cDNA 2700049A03 gene |
chr10_+_25408346 | 0.43 |
ENSMUST00000092645.6
|
Epb4.1l2
|
erythrocyte protein band 4.1-like 2 |
chrX_+_36328353 | 0.43 |
ENSMUST00000016383.3
|
Lonrf3
|
LON peptidase N-terminal domain and ring finger 3 |
chr11_-_100397740 | 0.43 |
ENSMUST00000001592.8
ENSMUST00000107403.1 |
Jup
|
junction plakoglobin |
chr11_-_102365111 | 0.42 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr9_-_60838200 | 0.42 |
ENSMUST00000063858.7
|
Gm9869
|
predicted gene 9869 |
chr13_-_98815408 | 0.42 |
ENSMUST00000040340.8
ENSMUST00000099277.4 ENSMUST00000179563.1 ENSMUST00000109403.1 |
Fcho2
|
FCH domain only 2 |
chr11_+_70092653 | 0.42 |
ENSMUST00000143772.1
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr9_-_16378231 | 0.42 |
ENSMUST00000082170.5
|
Fat3
|
FAT tumor suppressor homolog 3 (Drosophila) |
chr6_+_124916863 | 0.42 |
ENSMUST00000069553.2
|
A230083G16Rik
|
RIKEN cDNA A230083G16 gene |
chr4_+_33132552 | 0.42 |
ENSMUST00000182186.1
|
Gabrr1
|
gamma-aminobutyric acid (GABA) C receptor, subunit rho 1 |
chr1_-_64121389 | 0.42 |
ENSMUST00000055001.3
|
Klf7
|
Kruppel-like factor 7 (ubiquitous) |
chr3_-_88951146 | 0.42 |
ENSMUST00000173135.1
|
Dap3
|
death associated protein 3 |
chr8_-_85380964 | 0.41 |
ENSMUST00000122452.1
|
Mylk3
|
myosin light chain kinase 3 |
chr1_+_87404916 | 0.41 |
ENSMUST00000173152.1
ENSMUST00000173663.1 |
Gigyf2
|
GRB10 interacting GYF protein 2 |
chr13_-_93499803 | 0.41 |
ENSMUST00000065537.7
|
Jmy
|
junction-mediating and regulatory protein |
chr11_-_48946148 | 0.41 |
ENSMUST00000104958.1
|
Psme2b
|
protease (prosome, macropain) activator subunit 2B |
chr12_-_84400929 | 0.41 |
ENSMUST00000122194.1
|
Entpd5
|
ectonucleoside triphosphate diphosphohydrolase 5 |
chr7_+_44849581 | 0.41 |
ENSMUST00000150335.1
ENSMUST00000107882.1 |
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chr12_-_98737405 | 0.41 |
ENSMUST00000170188.1
|
Ptpn21
|
protein tyrosine phosphatase, non-receptor type 21 |
chr6_+_34709610 | 0.41 |
ENSMUST00000031775.6
|
Cald1
|
caldesmon 1 |
chr11_+_70213910 | 0.40 |
ENSMUST00000171032.1
|
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr4_-_45108038 | 0.40 |
ENSMUST00000107809.2
ENSMUST00000107808.2 ENSMUST00000107807.1 ENSMUST00000107810.2 |
Tomm5
|
translocase of outer mitochondrial membrane 5 homolog (yeast) |
chr8_-_36953139 | 0.40 |
ENSMUST00000179501.1
|
Dlc1
|
deleted in liver cancer 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
1.0 | 9.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.8 | 3.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) negative regulation of nodal signaling pathway(GO:1900108) |
0.6 | 10.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 2.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 1.6 | GO:0099578 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
0.5 | 1.4 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.5 | 1.4 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
0.5 | 1.9 | GO:1904008 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
0.4 | 1.1 | GO:0042271 | unidimensional cell growth(GO:0009826) susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 0.9 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.3 | 0.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 1.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 0.5 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.2 | 1.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.2 | 0.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.6 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 0.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 1.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.9 | GO:2000078 | columnar/cuboidal epithelial cell maturation(GO:0002069) positive regulation of type B pancreatic cell development(GO:2000078) |
0.2 | 1.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 1.0 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.2 | 0.8 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.2 | 0.5 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.6 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.1 | 1.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 1.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 1.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.4 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.1 | 0.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.4 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 1.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.9 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 1.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.7 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 2.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 2.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 1.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.2 | GO:1905203 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) regulation of connective tissue replacement(GO:1905203) |
0.1 | 2.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 1.1 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 0.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 2.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 2.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 1.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 1.0 | GO:0072431 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 1.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 1.5 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 1.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.7 | GO:1902475 | L-glutamate transmembrane transport(GO:0089711) L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 1.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.2 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.7 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.1 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 2.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.6 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 5.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.6 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.0 | 0.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 1.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.0 | 0.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 2.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.2 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.0 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.0 | 1.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.8 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.4 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.3 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.0 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.0 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.1 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.0 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.3 | GO:0090308 | maintenance of DNA methylation(GO:0010216) regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0033625 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) positive regulation of integrin activation(GO:0033625) protein secretion by platelet(GO:0070560) |
0.0 | 1.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.3 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 1.4 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 1.1 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.1 | GO:2000739 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 1.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.6 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.0 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.6 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.0 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.5 | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.8 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 1.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 10.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 2.7 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.7 | 9.8 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 1.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.4 | 1.6 | GO:1902737 | viral replication complex(GO:0019034) dendritic filopodium(GO:1902737) |
0.4 | 1.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.2 | 0.9 | GO:0014802 | terminal cisterna(GO:0014802) |
0.2 | 1.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 2.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.7 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 1.1 | GO:0031673 | H zone(GO:0031673) |
0.2 | 1.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 1.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.6 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 0.4 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.1 | 1.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.3 | GO:0043512 | inhibin A complex(GO:0043512) |
0.1 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 1.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.1 | 1.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 3.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 1.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 1.4 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 1.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.0 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 1.4 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.4 | 1.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 3.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 0.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.3 | 1.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 1.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 9.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 0.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 1.0 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.2 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 11.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 3.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 2.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.3 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.3 | GO:0005152 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 receptor antagonist activity(GO:0005152) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.1 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.1 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 2.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 2.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 2.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 10.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 1.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.2 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.1 | 0.2 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.1 | 1.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0048248 | CCR10 chemokine receptor binding(GO:0031735) CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 3.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 1.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 1.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 1.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 1.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.0 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 1.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 1.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.6 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 1.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 12.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 10.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 2.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 3.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 3.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 1.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 4.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 9.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 1.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 1.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 4.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.9 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |